<p>Cary Street Partners Financial LLC 在最近提交给证券交易委员会的 13F 表格中表示，在第二季度将其在贝克顿、迪金森公司（NYSE:BDX - 免费报告）的股份减少了 58.6%。该公司在此期间出售了 5,556 股后，持有 3,930 股该医疗仪器供应商的股票。Cary Street Partners Financial LLC 在贝克顿、迪金森公司的持股在最近一个季度末价值 677,000 美元。</p>
<ul>
<li>直觉外科公司提供从其 52 周高点的买入机会</li>
</ul>
<p>其他机构投资者和对冲基金最近也买卖了该公司的股票。先锋集团在第二季度将其在贝克顿、迪金森公司的股份增加了 15.4%。先锋集团现在拥有 32,308,749 股该医疗仪器供应商的股票，价值 5,565,182,000 美元，此前在上个季度购买了额外的 4,305,947 股。挪威银行在第二季度获得了贝克顿、迪金森公司的新头寸，价值约 653,377,000 美元。第一鹰投资管理公司在第二季度将其在贝克顿、迪金森公司的股份增加了 59.2%。第一鹰投资管理公司现在拥有 8,786,190 股该医疗仪器供应商的股票，价值 1,513,421,000 美元，此前在上个季度购买了额外的 3,268,478 股。GQG Partners LLC 在第一季度获得了贝克顿、迪金森公司的新股份，价值 689,833,000 美元。最后，马萨诸塞金融服务公司在第二季度将其在贝克顿、迪金森公司的股份增加了 24.4%。马萨诸塞金融服务公司现在拥有 8,514,446 股该医疗仪器供应商的股票，价值 1,466,613,000 美元，此前在上个季度获得了额外的 1,670,590 股。86.97% 的股票由机构投资者和对冲基金持有。</p>
<h2>内部人士下注</h2>
<p>在贝克顿、迪金森公司的其他消息中，董事贝特拉姆·L·斯科特于 11 月 7 日星期五出售了 217 股公司的股票。该股票以平均价格 176.58 美元出售，总价值为 38,317.86 美元。交易后，该董事直接持有 35,816 股公司的股票，价值 6,324,389.28 美元。这代表其持股减少了 0.60%。该出售在向 SEC 提交的文件中披露，文件可通过此超链接获取。在上个季度，内部人士出售了价值 73,922 美元的 407 股公司股票。公司内部人士持有 0.36% 的公司股票。</p>
<h2>分析师升级和降级</h2>
<ul>
<li>至少有 30 年分红增长的医疗保健股票</li>
</ul>
<p>一些股票研究分析师最近对该公司发布了报告。阿古斯在 9 月 15 日的研究报告中将贝克顿、迪金森公司的目标价格从 220.00 美元上调至 230.00 美元。派珀·桑德勒在 11 月 7 日的研究报告中将贝克顿、迪金森公司的目标价格从 200.00 美元下调至 190.00 美元，并对该股票给予 “中性” 评级。摩根士丹利在 12 月 2 日的研究报告中将贝克顿、迪金森公司的目标价格从 197.00 美元上调至 210.00 美元，并给予该公司 “增持” 评级。加拿大皇家银行在 11 月 7 日的研究报告中将贝克顿、迪金森公司的目标价格从 211.00 美元下调至 202.00 美元，并对该股票给予 “行业表现” 评级。最后，韦斯评级在 10 月 8 日的研究报告中重申了对贝克顿、迪金森公司的 “持有（c-）” 评级。四位分析师对该股票给予买入评级，九位分析师对该公司的股票给予持有评级。根据 MarketBeat 的数据，贝克顿、迪金森公司的平均评级为 “持有”，平均目标价格为 204.91 美元。</p>
<p><strong>阅读我们最新的 BDX 股票分析</strong></p>
<h2>贝克顿、迪金森公司的价格表现</h2>
<p>NYSE BDX 周四开盘价为 198.44 美元。该公司的债务与股本比率为 0.69，流动比率为 1.11，速动比率为 0.64。该公司的市值为 566.4 亿美元，市盈率为 34.04，市盈率增长比率为 1.74，贝塔值为 0.25。该公司的 50 日简单移动平均线为 188.58 美元，200 日简单移动平均线为 184.19 美元。贝克顿、迪金森公司的 52 周低点为 162.29 美元，52 周高点为 251.99 美元。</p>
<p>贝克顿、迪金森公司（NYSE:BDX - 获取免费报告）最后一次发布季度收益数据是在 4 月 14 日星期四。该医疗仪器供应商报告该季度每股收益为 4.10 美元。该公司该季度的收入为 53.2 亿美元。贝克顿、迪金森公司的净利润率为 7.68%，股本回报率为 16.42%。股票研究分析师预测，贝克顿、迪金森公司将在当前财政年度发布每股收益 14.43 美元。</p>
<h2>贝克顿、迪金森公司增加分红</h2>
<p>该公司最近还披露了一项季度分红，将于 12 月 31 日星期三支付。12 月 8 日星期一的登记投资者将获得每股 1.05 美元的分红。该分红的除息日为 12 月 8 日星期一。这是贝克顿、迪金森公司之前每季度 1.04 美元分红的积极变化。这代表年化分红为 4.20 美元，收益率为 2.1%。贝克顿、迪金森公司的派息比率为 72.04%。</p>
<h2>贝克顿、迪金森公司公司简介</h2>
<p>（免费报告）</p>
<p>贝克顿、迪金森公司开发、制造和销售医疗用品、设备、实验室设备和诊断产品，服务于全球的医疗机构、医生、生命科学研究人员、临床实验室、制药行业和公众。该公司分为三个部门：BD 医疗、BD 生命科学和 BD 介入。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票：Becton, Dickinson and Company</li>
<li>使用 MarketBeat 股息税计算器</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>便士股票适合你的投资组合吗？</li>
<li>Casey’s General Stores 将继续上涨的 3 个理由</li>
<li>支撑与阻力的基础知识</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
<p><strong>想知道其他对 BDX 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Becton, Dickinson and Company (NYSE:BDX - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元于 Becton, Dickinson and Company 吗？</h2>
<p>在考虑 Becton, Dickinson and Company 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Becton, Dickinson and Company 并不在名单上。</p>
<p>虽然 Becton, Dickinson and Company 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

碧迪医疗

<p>Cary Street Partners Financial LLC 在第二季度根据最新的 SEC 文件减少了对碧迪医疗（NYSE:BDX）58.6% 的持仓。该公司出售了 5,556 股，保留了价值 67.7 万美元的 3,930 股。其他机构投资者也调整了他们的持仓。分析师对 BDX 的评级不一，平均目标价为 204.91 美元。该股票周四以 198.44 美元开盘，市值为 566.4 亿美元</p>

<p>Cary Street Partners Financial LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 58.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 3,930 shares of the medical instruments supplier's stock after selling 5,556 shares during the period. Cary Street Partners Financial LLC's holdings in Becton, Dickinson and Company were worth $677,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Cary Street Partners Financial LLC 在最近提交给证券交易委员会的 13F 表格中表示，在第二季度将其在贝克顿、迪金森公司（NYSE:BDX - 免费报告）的股份减少了 58.6%。该公司在此期间出售了 5,556 股后，持有 3,930 股该医疗仪器供应商的股票。Cary Street Partners Financial LLC 在贝克顿、迪金森公司的持股在最近一个季度末价值 677,000 美元。</p>
</div><ul>
<li>Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs</li>
</ul>
<div class="lb-trans"><ul>
<li>直觉外科公司提供从其 52 周高点的买入机会</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Becton, Dickinson and Company by 15.4% in the 2nd quarter. Vanguard Group Inc. now owns 32,308,749 shares of the medical instruments supplier's stock worth $5,565,182,000 after purchasing an additional 4,305,947 shares in the last quarter. Norges Bank acquired a new position in Becton, Dickinson and Company in the second quarter worth approximately $653,377,000. First Eagle Investment Management LLC increased its holdings in shares of Becton, Dickinson and Company by 59.2% in the second quarter. First Eagle Investment Management LLC now owns 8,786,190 shares of the medical instruments supplier's stock valued at $1,513,421,000 after buying an additional 3,268,478 shares in the last quarter. GQG Partners LLC acquired a new stake in shares of Becton, Dickinson and Company during the 1st quarter valued at $689,833,000. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Becton, Dickinson and Company by 24.4% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,514,446 shares of the medical instruments supplier's stock worth $1,466,613,000 after acquiring an additional 1,670,590 shares in the last quarter. 86.97% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也买卖了该公司的股票。先锋集团在第二季度将其在贝克顿、迪金森公司的股份增加了 15.4%。先锋集团现在拥有 32,308,749 股该医疗仪器供应商的股票，价值 5,565,182,000 美元，此前在上个季度购买了额外的 4,305,947 股。挪威银行在第二季度获得了贝克顿、迪金森公司的新头寸，价值约 653,377,000 美元。第一鹰投资管理公司在第二季度将其在贝克顿、迪金森公司的股份增加了 59.2%。第一鹰投资管理公司现在拥有 8,786,190 股该医疗仪器供应商的股票，价值 1,513,421,000 美元，此前在上个季度购买了额外的 3,268,478 股。GQG Partners LLC 在第一季度获得了贝克顿、迪金森公司的新股份，价值 689,833,000 美元。最后，马萨诸塞金融服务公司在第二季度将其在贝克顿、迪金森公司的股份增加了 24.4%。马萨诸塞金融服务公司现在拥有 8,514,446 股该医疗仪器供应商的股票，价值 1,466,613,000 美元，此前在上个季度获得了额外的 1,670,590 股。86.97% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Becton, Dickinson and Company news, Director Bertram L. Scott sold 217 shares of the company's stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $176.58, for a total value of $38,317.86. Following the transaction, the director directly owned 35,816 shares of the company's stock, valued at $6,324,389.28. This represents a 0.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last quarter, insiders sold 407 shares of company stock valued at $73,922. Corporate insiders own 0.36% of the company's stock.</p>
<div class="lb-trans"><p>在贝克顿、迪金森公司的其他消息中，董事贝特拉姆·L·斯科特于 11 月 7 日星期五出售了 217 股公司的股票。该股票以平均价格 176.58 美元出售，总价值为 38,317.86 美元。交易后，该董事直接持有 35,816 股公司的股票，价值 6,324,389.28 美元。这代表其持股减少了 0.60%。该出售在向 SEC 提交的文件中披露，文件可通过此超链接获取。在上个季度，内部人士出售了价值 73,922 美元的 407 股公司股票。公司内部人士持有 0.36% 的公司股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><ul>
<li>Healthcare Stocks With at Least 30 Years of Dividend Increases</li>
</ul>
<div class="lb-trans"><ul>
<li>至少有 30 年分红增长的医疗保健股票</li>
</ul>
</div><p>A number of equities research analysts have recently issued reports on the company. Argus boosted their target price on Becton, Dickinson and Company from $220.00 to $230.00 in a research report on Monday, September 15th. Piper Sandler dropped their price target on Becton, Dickinson and Company from $200.00 to $190.00 and set a &#34;neutral&#34; rating on the stock in a research note on Friday, November 7th. Morgan Stanley upped their price objective on shares of Becton, Dickinson and Company from $197.00 to $210.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, December 2nd. Royal Bank Of Canada dropped their target price on shares of Becton, Dickinson and Company from $211.00 to $202.00 and set a &#34;sector perform&#34; rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Becton, Dickinson and Company in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, Becton, Dickinson and Company has an average rating of &#34;Hold&#34; and an average price target of $204.91.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对该公司发布了报告。阿古斯在 9 月 15 日的研究报告中将贝克顿、迪金森公司的目标价格从 220.00 美元上调至 230.00 美元。派珀·桑德勒在 11 月 7 日的研究报告中将贝克顿、迪金森公司的目标价格从 200.00 美元下调至 190.00 美元，并对该股票给予 “中性” 评级。摩根士丹利在 12 月 2 日的研究报告中将贝克顿、迪金森公司的目标价格从 197.00 美元上调至 210.00 美元，并给予该公司 “增持” 评级。加拿大皇家银行在 11 月 7 日的研究报告中将贝克顿、迪金森公司的目标价格从 211.00 美元下调至 202.00 美元，并对该股票给予 “行业表现” 评级。最后，韦斯评级在 10 月 8 日的研究报告中重申了对贝克顿、迪金森公司的 “持有（c-）” 评级。四位分析师对该股票给予买入评级，九位分析师对该公司的股票给予持有评级。根据 MarketBeat 的数据，贝克顿、迪金森公司的平均评级为 “持有”，平均目标价格为 204.91 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on BDX</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 BDX 股票分析</strong></p>
</div><h2>Becton, Dickinson and Company Price Performance</h2>
<div class="lb-trans"><h2>贝克顿、迪金森公司的价格表现</h2>
</div><p>NYSE BDX opened at $198.44 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.11 and a quick ratio of 0.64. The firm has a market capitalization of $56.64 billion, a price-to-earnings ratio of 34.04, a price-to-earnings-growth ratio of 1.74 and a beta of 0.25. The company has a 50 day simple moving average of $188.58 and a 200-day simple moving average of $184.19. Becton, Dickinson and Company has a 52-week low of $162.29 and a 52-week high of $251.99.</p>
<div class="lb-trans"><p>NYSE BDX 周四开盘价为 198.44 美元。该公司的债务与股本比率为 0.69，流动比率为 1.11，速动比率为 0.64。该公司的市值为 566.4 亿美元，市盈率为 34.04，市盈率增长比率为 1.74，贝塔值为 0.25。该公司的 50 日简单移动平均线为 188.58 美元，200 日简单移动平均线为 184.19 美元。贝克顿、迪金森公司的 52 周低点为 162.29 美元，52 周高点为 251.99 美元。</p>
</div><p>Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings data on Thursday, April 14th. The medical instruments supplier reported $4.10 earnings per share for the quarter. The firm had revenue of $5.32 billion for the quarter. Becton, Dickinson and Company had a net margin of 7.68% and a return on equity of 16.42%. Equities research analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>贝克顿、迪金森公司（NYSE:BDX - 获取免费报告）最后一次发布季度收益数据是在 4 月 14 日星期四。该医疗仪器供应商报告该季度每股收益为 4.10 美元。该公司该季度的收入为 53.2 亿美元。贝克顿、迪金森公司的净利润率为 7.68%，股本回报率为 16.42%。股票研究分析师预测，贝克顿、迪金森公司将在当前财政年度发布每股收益 14.43 美元。</p>
</div><h2>Becton, Dickinson and Company Increases Dividend</h2>
<div class="lb-trans"><h2>贝克顿、迪金森公司增加分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 31st. Investors of record on Monday, December 8th will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Monday, December 8th. This is a positive change from Becton, Dickinson and Company's previous quarterly dividend of $1.04. This represents a $4.20 dividend on an annualized basis and a yield of 2.1%. Becton, Dickinson and Company's payout ratio is 72.04%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 12 月 31 日星期三支付。12 月 8 日星期一的登记投资者将获得每股 1.05 美元的分红。该分红的除息日为 12 月 8 日星期一。这是贝克顿、迪金森公司之前每季度 1.04 美元分红的积极变化。这代表年化分红为 4.20 美元，收益率为 2.1%。贝克顿、迪金森公司的派息比率为 72.04%。</p>
</div><h2>Becton, Dickinson and Company Company Profile</h2>
<div class="lb-trans"><h2>贝克顿、迪金森公司公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.</p>
<div class="lb-trans"><p>贝克顿、迪金森公司开发、制造和销售医疗用品、设备、实验室设备和诊断产品，服务于全球的医疗机构、医生、生命科学研究人员、临床实验室、制药行业和公众。该公司分为三个部门：BD 医疗、BD 生命科学和 BD 介入。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Becton, Dickinson and Company</li>
<li>Using the MarketBeat Dividend Tax Calculator</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>The Basics of Support and Resistance</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票：Becton, Dickinson and Company</li>
<li>使用 MarketBeat 股息税计算器</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>便士股票适合你的投资组合吗？</li>
<li>Casey’s General Stores 将继续上涨的 3 个理由</li>
<li>支撑与阻力的基础知识</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding BDX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对 BDX 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Becton, Dickinson and Company (NYSE:BDX - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=BDX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Becton, Dickinson and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元于 Becton, Dickinson and Company 吗？</h2>
</div><p>Before you consider Becton, Dickinson and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Becton, Dickinson and Company 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Becton, Dickinson and Company 并不在名单上。</p>
</div><p>While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Becton, Dickinson and Company 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cary Street Partners Financial LLC 出售了碧迪医疗公司 $BDX 的股份